(-)-EMTRICITABINE S-OXIDE (MIXTURE OF DIASTEREOMERS)(CAS: 152128-77-3)

Emtricitabine sulfoxide (CAS: 152128-77-3) is subject to regulatory guidelines under the Globally Harmonized System (GHS) for classification and labeling of chemicals, REACH regulations in the European Union, and FDA and EPA guidelines in the United States. Producers and distributors must ensure compliance with local and international regulations regarding safety data sheets, hazard communication, and environmental protection.

Emtricitabine sulfoxide (CAS: 152128-77-3) is often used in the synthesis of antiretroviral drugs. While there are no direct alternatives, researchers may explore other sulfoxides or other antiviral compounds as substitutes depending on the specific reaction conditions and desired outcomes. Common alternative reagents include other sulfur-containing compounds that can serve similar functional group transformations.

The market for Emtricitabine sulfoxide (CAS: 152128-77-3) is closely tied to the broader market for antiretroviral drugs. Research trends indicate a focus on the development of more effective and less toxic antiretroviral therapies. Market analysis shows an increasing demand for emtricitabine-based formulations due to their efficacy in treating HIV/AIDS. Investigative research is also exploring the potential for emtricitabine sulfoxide derivatives in other therapeutic areas such as hepatitis B treatment.

Waste containing Emtricitabine sulfoxide (CAS: 152128-77-3) should be handled in accordance with local regulations. Typically, this involves proper collection, neutralization, and incineration or disposal by a certified hazardous waste management company. Environmental protection precautions include minimizing waste generation and ensuring that all waste is properly labeled and segregated to prevent the release of harmful substances into the environment.